Share Name Share Symbol Market Type Share ISIN Share Description
Hutchison China Meditech LSE:HCM London Ordinary Share KYG4672N1016 ORD USD1
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +40.00p +0.85% 4,765.00p 4,730.00p 4,800.00p 4,765.00p 4,750.00p 4,750.00p 6,309 14:31:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 175.0 -38.3 16.2 332.8 2,894.74

Hutchison China Meditech (HCM) Latest News

More Hutchison China Meditech News
Hutchison China Meditech Takeover Rumours

Hutchison China Meditech (HCM) Share Charts

1 Year Hutchison China Meditech Chart

1 Year Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

Intraday Hutchison China Meditech Chart

Intraday Hutchison China Meditech Chart

Hutchison China Meditech (HCM) Discussions and Chat

Hutchison China Meditech Forums and Chat

Date Time Title Posts
22/2/201807:15(Chi-Med)Hutchinson China Meditech Limited1,303
13/6/201706:54Hutchison China Meditech- CHARTS AND DISCUSSION74

Add a New Thread

Hutchison China Meditech (HCM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Hutchison China Meditech trades in real-time

Hutchison China Meditech (HCM) Top Chat Posts

DateSubject
25/2/2018
08:20
Hutchison China Meditech Daily Update: Hutchison China Meditech is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchison China Meditech was 4,725p.
Hutchison China Meditech has a 4 week average price of 4,305p and a 12 week average price of 4,305p.
The 1 year high share price is 5,920p while the 1 year low share price is currently 2,085p.
There are currently 60,750,132 shares in issue and the average daily traded volume is 7,415 shares. The market capitalisation of Hutchison China Meditech is £2,894,743,789.80.
13/2/2018
08:11
lauders: Well I thought the RNS today was worth a bit of reaction re: the share price. Obviously not but odd it is not showing in the header: Https://www.investegate.co.uk/hutchison-china-medi--hcm-/rns/enrolment-completed-ph-iii-faluca-fruquintinib/201802130701107097E/
12/2/2018
13:15
lauders: Thank you Nerdofsteel. Appreciate the feedback. Your reply makes sense, so it could be a win-win. If positive the share price will likely increase in turn, if negative it will drop but allow those with the future in mind to add more and benefit from marketing freely and perhaps penning an alternative deal. Can Lilly risk the latter? Now let's just see what the Nasdaq does today. If it is a good day the share price will recover. If not we could be going down again.
10/2/2018
09:19
carcosa: Why do you need reassuring? Recent share price decline is in line with world stock market changes.
09/2/2018
22:58
lauders: Perhaps foolish but I bought in on this dip! Seems too steep so either bad news is on the way or it is just a major correction on a frothy share price and is due a change in direction soon. Obviously I am hoping for the latter! RSI makes it a buy at least. One of the things I found during my due diligence into HCM: Https://www.astrazeneca.com/Partnering/partnering-case-studies/chi-med.html#modal-generic I wasn't aware of the video before even if it is a bit dated now.
01/2/2018
15:46
nerdofsteel: Frustrating price drift on NASDAQ which I suspect is simply down to the lack of news for the last few months. In my long experience of investing in the Company, we've had periods like this, and often when material news comes it comes in waves. I also notice when there's a long quiet period when we do get news it's usually extremely interesting and very very material, causing a significant positive impact on the share price.
25/1/2018
15:27
reptile3: I think the share price is simply returning to its support line (letting the traders take their 5% - 10%) before resuming its upward trajectory. If correct expect a turning point around £50 - £51 or $33 on the NASDAQ. ....... IMO.
10/1/2018
16:32
reptile3: I don't want to lower the tone of the thread which is exemplary in my opinion but does anyone have any idea what effect Chinese government approval of the licence would have on the share price?
31/12/2017
16:25
nerdofsteel: miti - good call, we also have Eli Lilly's last chance to decide if they want to take up global rights to Fruquintinib, and if they do they'll have to make a big lump sum payment which will radicalley alter our 2018 numbers. This will be a $20bn mcap company in the next 5 years IMO My 2017 share price target of £52ish has been trounced completely! My 2018 calendar year end proce target is £61 but there's every chance that could be hit in January.....clearly I need to re-visit my valuationm model....£250 by 2026
29/12/2017
16:01
reptile3: At 3:53 UK time share price on NASDAQ = $39.86. Times 2 = $79.72 which equals £59.30. Another all time high. I agree that £100 next year looks very possible. A happy, healthy and prosperous new year to all.
27/10/2017
10:45
mad foetus: Amazing that nobody notices this company - incredible share price record, incredible prospects, massive positive response to fund raising, share price sharply up and nobody notices. LOL!
Hutchison China Meditech share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180225 12:00:24